22Apr 2017

SERUM CHEMERIN LEVELS IN OVARIECTOMIZED OSTEOPOROTIC RAT MODEL.

  • Lecturer of physiology, Department of Physiology, Faculty of Medicine, Zagazig University.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Chemerin is an adipocytokine that controls adipocyte differentiation and related to immune and inflammatory functions. Post-menopausal osteoporosis (PMOP) is the most common bone disease in females characterized by decreased bone mineral density (BMD); relationship between chemerin and osteoporosis remains unclear. Objective: To assess serum chemerin levels in osteoporotic rat model induced by ovariectomy, and to investigate the interplay between serum chemerin levels and BMD, also the impact of estradiol replacement therapy on chemerin levels and its association with BMD parameters. Material and methods: Three equal groups of adult female albino rats (n=12) were used; sham operated control (sham), ovariectomized (OVX) and OVX with estrogen replacement (OVX-ER) groups. Nine weeks after ovariectomy, serum analysis, bone BMD measurements and histopathology were done. Results: In OVX osteoporotic rat model, serum levels of chemerin were significantly elevated (P<0.001) when compared to other groups, and negatively correlated with BMD, Changes in OVX chemerin levels were significantly associated with the elevated insulin resistance. However, they were not associated with FSH or estradiol levels. Conclusion: OVX induced osteoporosis was associated with significant rising in chemerin levels which were associated with changes in insulin resistance rather than sex hormones. It can be hypothesized that the exact causative of PMOP extends beyond pituitary; ovarian axis to be metabolic and adiposity cross talks which needs more detailed investigations.

  1. Bancroft D and Cook J: Organic chelating agents for decalciflcation of bone. Stain technology, 28: 285, 1984.
  2. Belfield A and Goldberg D.M: Colourimetric determination of serum alkaline phosphatase. Enzyme, 12: 651, 1971.
  3. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P and Legroux-Gerot I: Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab; 96: 2703-13, 2011.
  4. CCAC (Canadian Council on Animal Care): Guide to the care and use of experimental animals. 2nd ed. Vol. 1. Bradda Printing Services, Ottawa, Ont, 1993.
  5. Cheung E, Tsang S, Bow C, Soong C and Yeung S: Bone loss during menopausal transition among southern Chinese women. Maturitas 69: 50?56, 2011.
  6. Doster GR, Yorke RE and Randle PJ: Ashing procedures for biological materials. Current Science, 3: 206, 1969.
  7. EL-Mesallamy HO, EL-derany MO and Hamdy NM.: Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med; 28: 1194?1200, 2011.
  8. Engin-?st?nY, ?ağlayan EK, G??men AY, and Polat MFPostmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels. J Menopausal Med, 22(2): 76?79, 2016.
  9. Fatima SS, Bozaoglu K, Rehman R, Alam F and Memon AS: Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One , 8: e57113, 2013.
  10. Babaei P, Mehdizadeh R, Ansar M M and Damirchi A: Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in ratsMenopause International, 16: 100?104, 2010.
  11. Garc?a-Contreras F, Paniagua R, Avila-D?az M, Cabrera-Mu?oz L, Mart?nez-Mu?iz I, Foyo-Niembro E and Amato D: Cola beverage consumption induces bone mineralization reduction in ovariectomized rats. Arch Med Res. 31(4):360-5, 2000.
  12. Garcia-Martin A, Reyes-Garcia R, Garcia-Castro JM, Rozas-Moreno P and Escobar-Jimenez F: Role of serum FSH measurement on bone resorption in postmenopausal women. Endocrine 41: 302?308, 2012.
  13. Gindler, H; Pollard, FM and Martin, JV: Colourimetric determination of serum calcium. Ann. Biochem., 20: 521, 1972.
  14. Goldenberg, H: Colourimetric determination of serum phosphorus. Clin. Chem., 12 : 871, 1966.
  15. Gourlay ML, Specker BL, Li C, Hammett-Stabler CA and Renner JB: Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women. Bone 50: 311 ?316, 2012.
  16. Gui Y, Silha J V and Murphy L J: Sexual Dimorphism and Regulation of Resistin, Adiponectin, and Leptin Expression in the Mouse Obesity Research 12:1481-1491, 2004.
  17. He J, Li JC, Xie H, Xu ZH, Sun YWand Shan Q: Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Dis Markers, 2015:786708,
  18. Iliou T, Anagnostopoulos CN, Stephanakis IM and Anastassopoulos G A: novel data preprocessing method for boosting neural network performance: a case study in osteoporosis prediction, Inf. Sci. 380: 92?100, 2015.
  19. Imai Y: Bone metabolism by sex hormones and gonadotropins. Clin Calcium 24: 815?819, 2014.
  20. Jiang G., Matsumoto H., and Fujii A: Mandible bone loss in osteoporosis rats. Journal of Bone and Mineral Metabolism, 21(6): 388?395, 2003.
  21. Kanaley J, Sames C, Swisher L, Swick AG, Pioutz-Synder LL and Steppan CM: Abdominal fat distribution in pre-and postmenopausal women: The impact of physical activity, age and menopausal status. Metabolism; 50: 976-82, 2001.
  22. Liu S, Cheng Y, Fan M, Chen D and Bian Z: FSH aggravates periodontitis-related bone loss in ovariectomized rats. J Dent Res 89: 366?371, 2010.
  23. Liu Y, Song CY and Wu SS: Novel adipokines and bone metabolism. Int J Endocrinol; 2013:895045, 2013.
  24. Liu Y, Song CY, Wu SS, Liang QH , Yuan LQ, and Liao EY: Novel Adipokines and Bone Metabolism .Review Article International Journal of Endocrinology Volume 2013, Article ID 895045, 9 pages, 2013.
  25. Matthews D, Hosker J, Rudenski A, Naylor B and Turner R: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28:412-419, 1985.
  26. Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia M. B and Mohiti A: Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients J Bone Miner Metab , 32:400?404, 2014.
  27. Muruganandan S, Dranse HJ and Rourke JL: Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells;31: 2172 ?82, 2013.
  28. Muruganandan S, Parlee SD and Rourke JL: Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem;286:23982 ?95, 2011.
  29. Muruganandan S, Roman AA and Sinal CJ: Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res; 25:222 ? 34, 2010.
  30. Novelli E, Padovani C and Cicogna A: Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol. Res. 41, 253-259, 2008.
  31. Prasannarong M, Saengsirisuwan V, Piyachaturawat P, and Suksamrarn A: Improvements of insulin resistance in ovariectomized rats by a novel phytoestrogen from Curcuma comosa Roxb. BMC Complementary and Alternative Medicine. 1212:28. DOI: 10.1186/1472-6882-12-28, 2012.
  32. Raab, J.K.; Alan, S.T. and Drury, W:Histological methods for bone, 5th, Oxford University Press, New York, Toronto, PP. 185, 1991.
  33. Ritter V, Thuering B, Saint Mezard P, Luong-Nguyen NH and Seltenmeyer Y: Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro. Calcif Tissue Int 82: 383?391, 2008.
  34. Roh SG, Song SH and Choi KC: Chemerin a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun; 362:1013 ?8, 2007.
  35. Rouach V, Katzburg S, Koch Y, Stern N and Somjen D: Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH. J Cell Biochem 112: 128?137,2011.
  36. Saengsirisuwan V, Pongseeda S, Prasannarong M, Vichaiwong K and Toskulkao C: Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism, 58(1): 38?47, 2009.
  37. Seibel MJ, Dunstan CR, Zhou H, Allan CM and Handelsman DJ: Sex steroids, not FSH, influence bone mass. Cell 127: 1079, 2006.
  38. Shi L, Mao C, Wang X, Liu R, Li L, Mou X, Xu P, Li H and Xu C: Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women Medicine , 95:35, 2016.
  39. Siri P W and Ginsberg H N: Ovariectomy leads to increased insulin resistance in human apolipoprotein B transgenic mice lacking brown adipose tissue. Metabolism, 52 (6):, , 659?661, 2003.
  40. Sowers MR, Jannausch M, McConnell D, Little R and Greendale GA: Hormone predictors ofbone mineral density changes during the menopausal transition. J Clin Endocrinol Metab, 91: 1261?1267, 2006.
  41. Sowers MR, Zheng H, Greendale GA, Neer RM and Cauley JA: Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity. J Clin Endocrinol Metab, 98: 2854?2863, 2013.
  42. Sun L, Peng Y, Sharrow AC, Iqbal J and Zhang Z: FSH directly regulates bone mass. Cell 125: 247?260, 2006.
  43. Tan bk, chen j, farhatullah s, adya r, kaur j, heutling d, lewandowski kc, o'hare jp, lehnert h and randeva s: Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes, 58:1971?1977, 2009.
  44. Temple R, Clark P and Hales C: Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Medicine 9: 503, 1992.
  45. Terzoudis S, Malliaraki N, Damilakis J, Dimitriadou DA, Zavos C and Koutroubakis IE: Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. Jul; 28(7):814-9, 2016.
  46. Terzoudis S, Malliaraki N, Damilakis J, Koutroumpakis E and Koutroubakis IE: Mo1258 Chemerin, Visfatin and Vaspin Serum Levels in Relation to Fat Mass and Bone Mineral Density in IBD Volume 146, Issue 5, Supplement 1, Pages?S-599?S-600,
  47. Tietz N: Clinical Guide to Laboratory Tests, 3rd Ed., W.B. Saunders Company, Philadelphia, 509?580, 1995.
  48. VAN POPPEL MN, ZECK W, ULRICH D, SCHEST EC, HIRSCHMUGL B and LANG U: Cord blood chemerin: differential effects of gestational diabetes mellitusand maternal obesity. Clin Endocrinol (Oxf), 80:65?72, 2014.
  49. Visseres D, Hens W, Taeymas J, Baeyens JP, Poortmas J and Gaal LV: The effect of exercise on visceral adipose tissue in overweight adults: A systematic review and meta-analysis. Diabetes Metab, 8: 56415, 2013.
  50. Wang J, Zhang W, Yu C, Zhang X, Zhang H, Guan Q, Zhao J and Xu J: Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation. PLoS One. 10(8):e0134986, 2015.
  51. won Muhlen D, Safii S, Jassal SK, Svartberg J and Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int. 18:1337?1344, 2007.
  52. Xin FE, Shengqiang LI, Yulian LA and Jirong GE : Correlational study between knee osteoarthritis and osteoporosis in postmenopausal women, Chin. J. Osteoporos./Zhongguo Guzhi Shusong Zazhi, 20 (4). 2014.
  53. Yang J, Farnell D, Devlin H, Horner K and Graham J: The effect of ovariectomy on mandibular cortical thickness in the rat. Journal of Dentistry, 33(2): 123?129, 2005.
  54. Ye Z, Wang S, Yang Z, He M, Zhang S, Zhang W, Wen J and Li Q: Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Mol Biol Rep. Mar; 41(3):1317-23, 2014.
  55. Zoth N, Weigt C, Zengin S, Selder O, Selke N and Kalicinski M: Metabolic effects of estrogen substitution in combination with targeted exercise training on the therapy of obesity in ovariectomized Wistar rats. J Steroid Biochem Mol Biol; 130: 64?72, 2012.

[Nadine Ahmad Raafat M.D. (2017); SERUM CHEMERIN LEVELS IN OVARIECTOMIZED OSTEOPOROTIC RAT MODEL. Int. J. of Adv. Res. 5 (Apr). 242-250] (ISSN 2320-5407). www.journalijar.com

Nadine Ahmad Raafat
Lecturer of physiology, Department of Physiology, Faculty of Medicine, Zagazig University

DOI:

Article DOI: 10.21474/IJAR01/3801      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3801

Download Full Paper

Download PDF No. of Downloads: 17 | No. of Views: 89